Tech Company Financing Transactions

Sialix Funding Round

Sialix, operating out of Newton, scored $1 million from Boston Harbor Angels, Maine Angels and private investors.

Transaction Overview

Company Name
Announced On
7/31/2013
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Series B
Investors

Boston Harbor Angels

Maine Angels

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
90 Bridge St. 100
Newton, MA 02458
USA
Email Address
Overview
Sialix is developing products based on new biological discoveries of non-human sialic acids, their dietary role and inflammatory consequences, and their potential impact on cancer, cardiovascular, and other inflammatory-mediated diseases.
Profile
Sialix LinkedIn Company Profile
Social Media
Sialix Company Twitter Account
Company News
Sialix News
Facebook
Sialix on Facebook
YouTube
Sialix on YouTube

Management Team

Title
Name
Email & Social
Chairman
Brad Curley
  Brad Curley LinkedIn Profile  Brad Curley Twitter Account  Brad Curley News  Brad Curley on Facebook
Chief Executive Officer
Jeffrey Behrens
  Jeffrey Behrens LinkedIn Profile  Jeffrey Behrens Twitter Account  Jeffrey Behrens News  Jeffrey Behrens on Facebook
VP - R & D
Daniel Dransfield
  Daniel Dransfield LinkedIn Profile  Daniel Dransfield Twitter Account  Daniel Dransfield News  Daniel Dransfield on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/31/2013: Social Tables venture capital transaction
Next: 7/31/2013: Apigee venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary